Projects per year
Personal profile
Personal Statement
Val Ferro read Biochemistry at the University of Aberdeen (BSc Hons 1985) and carried out postgraduate research into Tumour Biology at the University of St. Andrews. (PhD, 1989). She moved to the University of Strathclyde in 1989 as a Postdoctoral Research Fellow, managing commercially-funded projects on vaccine development. She became a lecturer in 2006 and was promoted to Senior Lecturer in 2018.
Research Interests
Current research interests within Dr Ferro's group focuses on three main areas: development of non-invasive human and veterinary vaccines, development of anti-fertility vaccines and natural product research.
Teaching Interests
Val teaches at both undergraduate (Years 1, 2 and 4) and postgraduate level.
Fingerprint
- 10 Similar Profiles
Network
Projects
-
Design of functional chitosan films: antimicrobial and heavy metal capture applications
BBSRC (Biotech & Biological Sciences Research Council)
1/10/20 → 30/09/24
Project: Research - Studentship
-
In silico design of high-affinity recombinant antibodies (IBioIC CTP)
BBSRC (Biotech & Biological Sciences Research Council)
1/02/20 → 31/01/24
Project: Research - Studentship Case
Research Output
-
Translational modifications to improve vaccine efficacy in an oral influenza vaccine
Bennett, E., Mullen, A. B. & Ferro, V. A., Dec 2009, In: Methods. 49, 4, p. 322-327 6 p.Research output: Contribution to journal › Article › peer-review
8 Citations (Scopus) -
Immunisation with a plasmid DNA vaccine encoding gonadotrophin releasing hormone (GnRH-I) and T-helper epitopes in saline suppresses rodent fertility
Khan, M. A. H., Ogita, K., Ferro, V. A., Kumasawa, K., Tsutsui, T. & Kimura, T., 4 Mar 2008, In: Vaccine. 26, 10, p. 1365-1374 10 p.Research output: Contribution to journal › Article › peer-review
27 Citations (Scopus)
Activities
-
University of Stirling (External organisation)
Valerie Ferro (Advisor)
Nov 2017 → 2018Activity: Membership types › Membership of board
-
South African Medical Research Council (External organisation)
Valerie Ferro (Advisor)
2017 → 2018Activity: Membership types › Membership of peer review panel or committee
Impacts
-
Economic benefit and competitive advantage from commercial adoption of an innovative non-invasive delivery method for drugs and vaccines
Katharine Carter (Participant), Valerie Ferro (Participant), Alexander Mullen (Participant) & James Alexander (Participant)
Impact: Impact - for External Portal › Economic and commerce, Health and welfare - new products, guidelines and services
File